| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.67B | 59.47B | 50.49B | 41.92B | 42.43B | 30.52B |
| Gross Profit | 22.01B | 20.83B | 17.56B | 14.21B | 13.49B | 7.38B |
| EBITDA | 7.99B | 7.22B | 6.16B | 4.23B | 4.86B | 152.19M |
| Net Income | 2.06B | 1.72B | 1.63B | 607.57M | 1.07B | -2.42B |
Balance Sheet | ||||||
| Total Assets | 43.69B | 44.11B | 40.83B | 36.86B | 30.91B | 35.14B |
| Cash, Cash Equivalents and Short-Term Investments | 4.11B | 3.79B | 4.33B | 2.75B | 3.58B | 3.82B |
| Total Debt | 19.36B | 19.13B | 17.18B | 17.84B | 12.73B | 16.79B |
| Total Liabilities | 31.31B | 32.10B | 29.94B | 27.38B | 22.00B | 27.36B |
| Stockholders Equity | 11.56B | 11.43B | 10.43B | 9.12B | 8.61B | 7.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 637.00M | 3.46B | -5.25B | 4.19B | -3.11B |
| Operating Cash Flow | 0.00 | 3.59B | 6.97B | -2.44B | 6.02B | -1.10B |
| Investing Cash Flow | 0.00 | -4.84B | -4.20B | -3.06B | -1.90B | -2.17B |
| Financing Cash Flow | 0.00 | 718.00M | -1.30B | 4.55B | -4.44B | 4.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥40.34B | 13.95 | ― | 2.40% | 13.49% | 9.05% | |
73 Outperform | ¥69.65B | 17.44 | ― | 2.73% | 6.41% | 16.71% | |
66 Neutral | ¥196.15B | 10.26 | 13.53% | 1.34% | 0.48% | -1.86% | |
62 Neutral | $5.92T | 29.16 | 6.73% | 1.99% | -6.96% | -7.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $22.26T | -100.09 | 14.45% | 0.55% | -2.86% | 5.93% | |
54 Neutral | ¥2.77B | -1.63 | ― | 4.68% | 3.64% | 37.31% |